ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645665 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645665; 2) Community: the network communities that were significantly associated with the response to NSC 645665; 3) Molecule: the relationships between components within communities and NSC 645665; 4) MDR: the compounds that were significantly associated with the NSC 645665.

NSC Compound Enrichment Correlation
NSC 112758 Rubomycin 0.0352383000003058 0.15603759
NSC 127328 Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- 0.0352383000003058 0.2473293
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0352383000003058 0.16079325
NSC 134725 K-33 0.0352383000003058 0.13968449
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0352383000003058 0.31863302
NSC 255111 19-Formylgeldanamycin N-piperidinoimine 0.0352383000003058 0.21108249
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.0352383000003058 0.2908369
NSC 264880 Dihydro-5-azacytidine 0.0352383000003058 0.24534905
NSC 359463 Null 0.0352383000003058 0.34396046
NSC 618296 Null 0.0352383000003058 0.33966769
Total:81  Current:57    [First] [Prev] [Next] [Last]